World Asset Management Inc bought a new stake in MAXIMUS, Inc. (NYSE:MMS) in the first quarter, Holdings Channel reports. The institutional investor bought 2,998 shares of the health services provider’s stock, valued at approximately $213,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of MMS. NumerixS Investment Technologies Inc raised its position in shares of MAXIMUS by 9.1% in the fourth quarter. NumerixS Investment Technologies Inc now owns 2,400 shares of the health services provider’s stock valued at $155,000 after purchasing an additional 200 shares during the period. HighPoint Advisor Group LLC bought a new position in shares of MAXIMUS in the fourth quarter valued at approximately $784,000. Dupont Capital Management Corp raised its position in shares of MAXIMUS by 190.8% in the fourth quarter. Dupont Capital Management Corp now owns 81,676 shares of the health services provider’s stock valued at $5,316,000 after purchasing an additional 53,593 shares during the period. Bessemer Group Inc. raised its position in shares of MAXIMUS by 38.9% in the fourth quarter. Bessemer Group Inc. now owns 49,597 shares of the health services provider’s stock valued at $3,228,000 after purchasing an additional 13,900 shares during the period. Finally, Cambiar Investors LLC raised its position in shares of MAXIMUS by 1.7% in the fourth quarter. Cambiar Investors LLC now owns 70,594 shares of the health services provider’s stock valued at $4,595,000 after purchasing an additional 1,163 shares during the period. Hedge funds and other institutional investors own 95.94% of the company’s stock.
In related news, Director Paul R. Lederer sold 6,715 shares of the business’s stock in a transaction on Wednesday, February 13th. The shares were sold at an average price of $70.04, for a total transaction of $470,318.60. Following the transaction, the director now owns 59,029 shares of the company’s stock, valued at $4,134,391.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Russell A. Beliveau sold 1,000 shares of the business’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $71.40, for a total transaction of $71,400.00. The disclosure for this sale can be found here. Insiders have sold 54,715 shares of company stock worth $3,873,949 in the last ninety days. 2.20% of the stock is currently owned by insiders.
MMS has been the topic of a number of recent analyst reports. Zacks Investment Research lowered shares of MAXIMUS from a “buy” rating to a “hold” rating in a research report on Tuesday, January 29th. ValuEngine lowered shares of MAXIMUS from a “buy” rating to a “hold” rating in a research report on Thursday, February 28th.
NYSE:MMS opened at $72.86 on Friday. MAXIMUS, Inc. has a 12 month low of $60.00 and a 12 month high of $74.18. The company has a market capitalization of $4.61 billion, a PE ratio of 20.25, a PEG ratio of 1.95 and a beta of 0.96. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.32 and a current ratio of 2.31.
MAXIMUS (NYSE:MMS) last announced its earnings results on Thursday, May 9th. The health services provider reported $0.96 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.91 by $0.05. MAXIMUS had a net margin of 8.76% and a return on equity of 21.19%. The business had revenue of $736.50 million for the quarter, compared to analyst estimates of $757.29 million. During the same quarter in the previous year, the firm posted $0.84 earnings per share. MAXIMUS’s revenue was up 20.2% compared to the same quarter last year. Analysts predict that MAXIMUS, Inc. will post 3.72 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Investors of record on Wednesday, May 15th will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date is Tuesday, May 14th. MAXIMUS’s dividend payout ratio (DPR) is currently 29.41%.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Read More: Gross Domestic Product (GDP)
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.